Islet-1 gene delivery improves myocardial performance after experimental infarction

Area of Science:

• Cardiovascular Biology
• Stem Cell Biology
• Regenerative Medicine

Background:

• The LIM-homeobox transcription factor Isl1 is vital for heart development and generates resident cardiac stem cells.
• Understanding extra-cardiac Isl1 stem cell populations and their behavior post-myocardial infarction (MI) is crucial for cardiac repair strategies.

Purpose of the Study:

• To identify novel extra-cardiac Isl1 stem cell populations.
• To investigate the dynamic expression of Isl1 in the heart after MI.
• To evaluate the therapeutic potential of intramyocardial Isl1 gene transfer for functional recovery post-MI.

Main Methods:

• Lineage tracing in transgenic mice (Isl1/cre/Z/EG) to identify extra-cardiac Isl1 stem cells.
• RT-PCR and FACS analysis to track endogenous Isl1 expression post-MI.
• Intramyocardial injection of naked DNA encoding Isl1 into the peri-infarct region of mouse hearts.
• Echocardiography, histological analysis of fibrosis, and vascularization assessment to evaluate cardiac function.

Main Results:

• Isl1 progenitor cells were identified in the bone marrow and spleen.
• Isl1 re-expression was observed in the spleen and left ventricle following MI.
• Intramyocardial Isl1 gene transfer partially restored left ventricular function.
• Enhanced vascularization and reduced myocardial fibrosis were noted in treated hearts.

Conclusions:

• Isl1 contributes to extra-cardiac stem cell populations and is dynamically regulated after cardiac injury.
• Intramyocardial Isl1 gene transfer demonstrates reparative potential, improving cardiac function and structure post-MI.
• The Isl1 gene represents a promising therapeutic target for managing myocardial dysfunction.